These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31064218)

  • 1. Advanced glycation end product carboxymethyl-lysine and risk of incident peripheral artery disease in older adults: The Cardiovascular Health Study.
    Garg PK; Biggs ML; Barzilay J; Djousse L; Hirsch C; Ix JH; Kizer JR; Tracy RP; Newman AB; Siscovick DS; Mukamal KJ
    Diab Vasc Dis Res; 2019 Sep; 16(5):483-485. PubMed ID: 31064218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced glycation/glycoxidation endproduct carboxymethyl-lysine and incidence of coronary heart disease and stroke in older adults.
    Kizer JR; Benkeser D; Arnold AM; Ix JH; Mukamal KJ; Djousse L; Tracy RP; Siscovick DS; Psaty BM; Zieman SJ
    Atherosclerosis; 2014 Jul; 235(1):116-21. PubMed ID: 24825341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Receptor for Advanced Glycation End Products (Rage) and Its Ligands in Plasma and Infrainguinal Bypass Vein.
    Malmstedt J; Frebelius S; Lengquist M; Jörneskog G; Wang J; Swedenborg J
    Eur J Vasc Endovasc Surg; 2016 Apr; 51(4):579-86. PubMed ID: 26905625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein-Associated Phospholipase A2 and Incident Peripheral Arterial Disease in Older Adults: The Cardiovascular Health Study.
    Garg PK; Arnold AM; Hinckley Stukovsky KD; Koro C; Jenny NS; Mukamal KJ; Criqui MH; Furberg CD; Newman AB; Cushman M
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):750-6. PubMed ID: 26848158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The receptor for advanced glycation end products and risk of peripheral arterial disease, amputation or death in type 2 diabetes: a population-based cohort study.
    Malmstedt J; Kärvestedt L; Swedenborg J; Brismar K
    Cardiovasc Diabetol; 2015 Jul; 14():93. PubMed ID: 26216409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboxymethyl lysine, an advanced glycation end product, and incident diabetes: a case-cohort analysis of the ARIC Study.
    Luft VC; Duncan BB; Schmidt MI; Chambless LE; Pankow JS; Hoogeveen RC; Couper DJ; Heiss G
    Diabet Med; 2016 Oct; 33(10):1392-8. PubMed ID: 26359784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum carboxymethyl-lysine, an advanced glycation end product, is associated with increased aortic pulse wave velocity in adults.
    Semba RD; Najjar SS; Sun K; Lakatta EG; Ferrucci L
    Am J Hypertens; 2009 Jan; 22(1):74-9. PubMed ID: 19023277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma carboxymethyl-lysine, an advanced glycation end product, and all-cause and cardiovascular disease mortality in older community-dwelling adults.
    Semba RD; Bandinelli S; Sun K; Guralnik JM; Ferrucci L
    J Am Geriatr Soc; 2009 Oct; 57(10):1874-80. PubMed ID: 19682127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating selenium and carboxymethyl-lysine, an advanced glycation endproduct, are independent predictors of anemia in older community-dwelling adults.
    Roy CN; Semba RD; Sun K; Bandinelli S; Varadhan R; Patel KV; Guralnik JM; Ferrucci L
    Nutrition; 2012 Jul; 28(7-8):762-6. PubMed ID: 22325035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations.
    Hammes HP; Brownlee M; Lin J; Schleicher E; Bretzel RG
    Diabetologia; 1999 May; 42(5):603-7. PubMed ID: 10333054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum carboxymethyl-lysine, an advanced glycation end product, is associated with arterial stiffness in older adults.
    Semba RD; Sun K; Schwartz AV; Varadhan R; Harris TB; Satterfield S; Garcia M; Ferrucci L; Newman AB;
    J Hypertens; 2015 Apr; 33(4):797-803; discussion 803. PubMed ID: 25915884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum advanced glycation endproducts are associated with left ventricular dysfunction in normal glucose metabolism but not in type 2 diabetes: The Hoorn Study.
    Linssen PB; Henry RM; Schalkwijk CG; Dekker JM; Nijpels G; Brunner-La Rocca HP; Stehouwer CD
    Diab Vasc Dis Res; 2016 Jul; 13(4):278-85. PubMed ID: 27190078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboxymethyl-lysine, an advanced glycation end product, and decline of renal function in older community-dwelling adults.
    Semba RD; Fink JC; Sun K; Bandinelli S; Guralnik JM; Ferrucci L
    Eur J Nutr; 2009 Feb; 48(1):38-44. PubMed ID: 19031098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women.
    Semba RD; Ferrucci L; Sun K; Beck J; Dalal M; Varadhan R; Walston J; Guralnik JM; Fried LP
    Aging Clin Exp Res; 2009 Apr; 21(2):182-90. PubMed ID: 19448391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum carboxymethyl-lysine, a dominant advanced glycation end product, is associated with chronic kidney disease: the Baltimore longitudinal study of aging.
    Semba RD; Fink JC; Sun K; Windham BG; Ferrucci L
    J Ren Nutr; 2010 Mar; 20(2):74-81. PubMed ID: 19853477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes.
    Koska J; Saremi A; Howell S; Bahn G; De Courten B; Ginsberg H; Beisswenger PJ; Reaven PD;
    Diabetes Care; 2018 Mar; 41(3):570-576. PubMed ID: 29208654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum advanced glycation end products and their circulating receptors are associated with anaemia in older community-dwelling women.
    Semba RD; Ferrucci L; Sun K; Patel KV; Guralnik JM; Fried LP
    Age Ageing; 2009 May; 38(3):283-9. PubMed ID: 19252206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ellisras Longitudinal Study 2017: elevated serum levels of carboxymethyl-lysine, an advanced glycation end-product, are associated with higher odds of developing endothelial dysfunction in black South African patients with type 2 diabetes mellitus (ELS 29).
    Mogale MA; Mhlanga CM; Gololo SS; Adu A
    Cardiovasc J Afr; 2019 Jul/Aug 23; 30(4):193-197. PubMed ID: 31469381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary intake of advanced glycation end products did not affect endothelial function and inflammation in healthy adults in a randomized controlled trial.
    Semba RD; Gebauer SK; Baer DJ; Sun K; Turner R; Silber HA; Talegawkar S; Ferrucci L; Novotny JA
    J Nutr; 2014 Jul; 144(7):1037-42. PubMed ID: 24744309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum carboxymethyl-lysine, disability, and frailty in older persons: the Cardiovascular Health Study.
    Whitson HE; Arnold AM; Yee LM; Mukamal KJ; Kizer JR; Djousse L; Ix JH; Siscovick D; Tracy RP; Thielke SM; Hirsch C; Newman AB; Zieman S
    J Gerontol A Biol Sci Med Sci; 2014 Jun; 69(6):710-6. PubMed ID: 24127427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.